Biopharmas raising money in public or private financings, including: Amryt, Arch Biopartners, Asclepix, Basilea, Bioaegis, Biosig, Compass, Cyclica, Editas, Forma, Hyloris, Reata, Repare, Simcha, Soleno.

New hires and promotions in the biopharma industry, including: Artax, Bridgebio, Cytovia, Nascent, Neuraptive.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Corat, Greenlight, Yumab.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Achilles Vaccines, Adamis, Agenus, Amarin, Amyndas, Apotex, Armata, Astrazeneca, Atyr, Avacta, Berg, Betta, Cascade Chemistry, Cellics, Cobra, Codagenix, Dr. Reddy’s, Farmacore, G1, Gelesis, Genor, Hikma, Immunoprecise Antibodies, Immuron, Innovation, Kalytera, Kamada, Kedrion, Lead Discovery Center, Leidos, Litevax, Matrix Biomed, Merck, Moleculin, Monopar, Nascent , Northstar Medical Radioisotopes, Olix, Oncolys, Orgenesis, PDS, Quartesian, Qurient, Renibus, Salzman, Staidson, Synairgen, Teva, Themis, Therapeutic Solutions, Tonix, Transcelerate, Treos.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aclaris, Ampio, Arch, Ascentage, Beigene, Bio-Thera, Curevac, Cynata, Edesa, Kyowa Kirin, Innovent, Kamada, Merck, Pear, PTC, Sanofi, Regeneron, Ultragenyx.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acadia, Aribio, Ascentage, Ascletis, Biosig Technologies, Clover, Eli Lilly, Evelo, Evgen, FSD, Hua Medicine, Humanigen, Inflarx, Innovent, Kiniksa, Neuren, Remegen, Ridgeback, Sagimet.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akili, Apyx Medical, Companion Medical, Miracor Medical, Neoteryx, Preceptis Medical, Royal Philips.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Archerdx, Artegraft, Bertin Instruments, Bioskryb, Brite-Strike Technologies, Demetech, Golden Vine International, Hawkeye Systems, Illumina, Inovio Pharmaceuticals, Illumina, Invictus Medical, Invitae, Invo Bioscience, Karten Design, Lemaitre Vascular, Litecure, Mbio Diagnostics, Misty Robotics, Myocardial Solutions, Nano-X Imaging, Northeast Scientific, Ocutrx Vision Technologies, Pathgroup, Pathogendx, Qiagen, Sengenics, Transenterix, Vitanova Biomedical, Xatek, Zimmer Biomet.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Draper, Rewalk, Viewray.

Med-tech firms raising money in public or private financings, including: Brightinsight, Carlsmed.